Roberto Bei Selected Research

5,7-dimethoxycoumarin

6/2009	Inhibition of Mek 1/2 kinase activity and stimulation of melanogenesis by 5,7-dimethoxycoumarin treatment of melanoma cells.
2/2008	Cell cycle arrest and differentiation induction by 5,7-dimethoxycoumarin in melanoma cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto Bei Research Topics

Disease

50	Neoplasms (Cancer) 12/2021 - 02/2007
12	Carcinoma (Carcinomatosis) 05/2020 - 11/2004
10	Malignant Mesothelioma 01/2022 - 11/2004
10	Inflammation (Inflammations) 11/2020 - 03/2003
7	Carcinogenesis 12/2021 - 02/2007
7	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2007
5	Neoplasm Metastasis (Metastasis) 03/2022 - 09/2012
4	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 03/2013
4	Necrosis 01/2022 - 02/2007
4	Melanoma (Melanoma, Malignant) 12/2015 - 02/2008
4	Squamous Cell Carcinoma of Head and Neck 11/2014 - 11/2004
4	Rupture 12/2006 - 03/2003
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 12/2007
3	Mesothelioma 04/2012 - 01/2008
3	Carotid Stenosis (Carotid Artery Stenosis) 12/2006 - 03/2003
3	Atherosclerotic Plaque (Atheroma) 12/2006 - 09/2003
2	Infarction (Infarctions) 01/2022 - 05/2017
2	Hypertension (High Blood Pressure) 11/2021 - 05/2017
2	Neuroblastoma 08/2021 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2017
2	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 01/2012
2	Glioma (Gliomas) 06/2018 - 01/2013
2	Ascites 01/2018 - 05/2017
2	Salivary Gland Neoplasms (Salivary Gland Cancer) 05/2017 - 05/2014
2	Osteoporosis 01/2017 - 03/2015
2	Colonic Neoplasms (Colon Cancer) 03/2015 - 07/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2013 - 12/2006
2	West Nile Fever 11/2012 - 04/2009
2	Infections 11/2012 - 01/2004
2	Gastroesophageal Reflux (GERD) 01/2010 - 07/2008
2	Wounds and Injuries (Trauma) 01/2010 - 07/2008
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2010 - 07/2008
2	Ulcer 01/2010 - 07/2008
2	Type 2 Diabetes Mellitus (MODY) 12/2006 - 09/2003
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
11	PolyphenolsIBA 10/2021 - 01/2013
9	CytokinesIBA 12/2021 - 04/2008
8	Biological ProductsIBA 11/2021 - 02/2007
8	VaccinesIBA 01/2021 - 01/2010
8	AntigensIBA 01/2017 - 01/2008
7	AntibodiesIBA 01/2017 - 11/2004
6	ErbB Receptors (EGF Receptor)IBA 01/2022 - 11/2004
5	CurcuminIBA 10/2021 - 01/2012
5	AutoantibodiesIBA 01/2020 - 12/2007
5	Matrix Metalloproteinases (MMPs)IBA 09/2016 - 03/2003
5	Pharmaceutical PreparationsIBA 05/2016 - 01/2008
5	EpitopesIBA 03/2015 - 02/2007
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 09/2016
4	AntioxidantsIBA 10/2021 - 09/2011
4	Myelin P0 Protein (Myelin Protein Zero)IBA 03/2015 - 12/2007
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2017
3	ResveratrolIBA 10/2021 - 01/2012
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 07/2008
3	GossypolIBA 01/2020 - 05/2017
3	Phosphotransferases (Kinase)IBA 06/2018 - 02/2008
3	FlavonoidsIBA 01/2017 - 09/2011
3	lissamine rhodamine B (sulforhodamine B)IBA 06/2016 - 01/2011
3	Protein Isoforms (Isoforms)IBA 06/2016 - 03/2003
3	Caspase 3 (Caspase-3)IBA 03/2015 - 01/2011
3	Cancer VaccinesIBA 05/2014 - 01/2010
2	EnzymesIBA 01/2022 - 06/2009
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 09/2012
2	NF-kappa B (NF-kB)IBA 08/2021 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 01/2010
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 01/2008
2	ProstaglandinsIBA 01/2021 - 03/2004
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021 - 09/2003
2	AutoantigensIBA 01/2020 - 01/2017
2	gossypol acetic acidIBA 01/2020 - 01/2018
2	ApigeninIBA 01/2017 - 01/2011
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 06/2016 - 01/2013
2	Carcinoembryonic AntigenIBA 12/2015 - 09/2012
2	Trypan Blue FDA Link 03/2015 - 02/2008
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2013 - 07/2008
2	CollagenIBA 03/2013 - 01/2013
2	Cadherins (E-Cadherin)IBA 09/2012 - 11/2003
2	Epidermal Growth Factor (EGF)IBA 09/2012 - 11/2004
2	CateninsIBA 09/2012 - 11/2003
2	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 01/2008
2	Histone Deacetylases (Histone Deacetylase)IBA 04/2011 - 01/2008
2	Sucralfate (Carafate)FDA LinkGeneric 01/2010 - 07/2008
2	Peptides (Polypeptides)IBA 01/2010 - 07/2007
2	5,7-dimethoxycoumarinIBA 06/2009 - 02/2008
2	Pemetrexed (MTA)FDA Link 04/2008 - 01/2008
2	Cisplatin (Platino)FDA LinkGeneric 04/2008 - 01/2008
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2008 - 12/2006
2	Simvastatin (Zocor)FDA LinkGeneric 12/2006 - 03/2003
2	Receptor for Advanced Glycation End ProductsIBA 12/2006 - 09/2003
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2004 - 03/2003
2	Metalloproteases (Metalloproteinases)IBA 03/2004 - 09/2003
2	Prostaglandins EIBA 09/2003 - 03/2003
1	Immune Checkpoint InhibitorsIBA 05/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022

Therapy/Procedure

12	Therapeutics 11/2021 - 01/2008
6	Immunotherapy 05/2022 - 09/2012
4	Radiotherapy 12/2021 - 11/2010
3	Drug Therapy (Chemotherapy) 01/2021 - 04/2008
3	Endarterectomy (Thromboendarterectomy) 12/2006 - 03/2003